Enhancement of radiosensitivity by roscovitine pretreatment in human non-small cell lung cancer A549 cells

Journal of Radiation Research

Volumn 49, Issue 5, 2008, Pages 541-548

  Zhang, Feng ^a   Zhang, Tao ^b   Gu, Zhong Ping ^b   Zhou, Yong An ^b   Han, Yong ^b   Li, Xiao Fei ^b   Wang, Xiao Ping ^b   Cheng, Qing Shu ^b   Mei, Qi Bing ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

A549 cells; Apoptosis; Caspase 3; DNA repair; Ionizing radiation; Roscovitine

Indexed keywords

BIOLOGICAL ORGANS; CELL CULTURE; DISEASES; DNA; FLOW CYTOMETRY; GAMMA RAYS; PROTEINS; RADIOTHERAPY; REPAIR;

A549 CELLS; CANCER CELL LINES; CASPASE-3; CELL-BE; CELL/B.E; CELL/BE; DNA-REPAIR; NON SMALL CELL LUNG CANCER; PRE-TREATMENTS; ROSCOVITINE;

CELL DEATH;

EID: 52249092188     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1269/jrr.08024     Document Type: Article

References (25)

1. Meijer, L., Borgne, A., Mulner, O., Chong, J. P.. Blow, J. J. and Inagaki, N. et al. (1997) Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biocheml. 243: 527-536.
2. Tirado, O. M., Mateo-Lozano, S. and Notario, V. (2005) Roscovitine is an effective inducer of apoptosis of Ewing's sarcoma family tumor cells in vitro and in vivo. Cancer Res. 65: 9320-9327.
3. Mohapatra, S., Chu, B., Zhao, X. H. and Pledger, W. J. (2005) Accumulation of p53 and reductions in XIAP abundance promote the apoptosis of prostate cancer cells. Cancer Res. 65: 7717-7723.
4. Wojciechowski, J., Horky, M., Gueorguieva, M. and Wesierska-Gadek, J. (2002) Rapid onset of nucleolar disintegration preceding cell cycle arrest in roscovitine-induced apoptosis of human MCF-7 breast cancer cells. Int J Cancer. 106: 486-495.
5. Mohapatra, S., Chu, B., Wei, S., Djeu, J., Epling-Bumette, P. K. and Loughran, T. et al. (2003) Roscovitine inhibits STAT5 activity and induces apoptosis in the human leukemia virus type 1-transformed cell line MT-2. Cancer Res. 63: 8523-8530.
6. Crescenzi, E., Palumbo, G. and Brady, H. J. (2005) Roscovitine Modulates DNA repair and senescence: implications for combination chemotherapy. Clin Cancer Res. 11: 8158-8171.
7. Maggiorella, L., Deutsch, E., Frascogna, V., Chavaudra, N., Jeanson, L. and Milliat, F. et al. (2003) Enhancement of radiation response by roscovitine in human breast carcinoma in Vitro and in Vivo. Cancer Res. 63: 2513-2517.
8. Mgbonyebi, O. P., Russo, J. and Russo, I. H. (1999) Roscovitine induces cell death and morphological changes indicative of apoptosis in MDA-MB-231 breast cancer cells. Cancer Res. 59: 1903-1910.
9. Hahntow, I. N., Schneller, F., Oelsner, M., Weick, K., Ringshausen, I. and Fend, F. et al. (2004) Cyclin dependent kinase inhibitor roscovitine induces apoptosis in chronic lym-phocytic leukemia cells. Leukemia. 18: 747-755.
10. Vermes, I., Haanen, C., Steffens-Nakken, H. and Reutelingsperger, C. (1995) A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V. J Immunol Methods. 184: 39-51.
11. Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G. and Earnshaw, W. C. (1994) Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature. 371: 346-347.
12. Raju, U., Nakata, E., Mason, K. A., Ang, K. K. and Milas, L. (2003) Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells. Cancer Res. 63: 3263-3267.
13. Palayoor, S. T., Macklis, R. M., Bump, E. A. and Coleman, C. N. (1995) Modulation of radiation-induced apoptosis and G2/M block in murine T-lymphoma cells. Radiat Res. 141: 235-243.
14. Ning, S. and Knox, S. J. (1999) G2/M-phase arrest and death by apoptosis of HL60 cells irradiated with exponentially decreasing low-dose-rate gamma radiation. Radiat Res. 151: 659-669.
15. Pawlik, T. M. and Keyomarsi, K. (2004) Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys. 59: 928-942.
16. Friesen, C., Glatting, G., Koop, B., Schwarz, K., Morgenstern, A. and Apostolidis, C. et al. (2007) Breaking chemoresistance and radioresistance with [213Bi] anti-CD45 antibodies in leukemia cells. Cancer Res. 67: 1950-1958.
17. Petermann, E. and Caldecott, K. W. (2006) Evidence that the ATR/Chk1 pathway maintains normal replication fork progression during unperturbed S phase. Cell Cycle. 5: 2203-2209.
18. Gross, A. (2006) BID as a double agent in cell life and death. Cell Cycle. 5: 582-584.
19. Collis, S. J., DeWeese, T. L., Jeggo, P. A. and Parker, A. R. (2005) The life and death of DNA-PK. Oncogene. 24: 949-961.
20. He, F., Li, L., Kim, D., Wen, B., Deng, X. and Gutin, P. H. et al. (2007) Adenovirus-mediated expression of a dominant negative Ku70 fragment radiosensitizes human tumor cells under aerobic and hypoxic conditions. Cancer Res. 67: 634-642.
21. Shintani, S., Mihara, M., Li, C., Nakahara, Y., Hino, S. and Nakashiro, K. et al. (2003) Up-regulation of DNA-dependent protein kinase correlates with radiation resistance in oral squamous cell carcinoma. Cancer Sci. 94: 894-900.
22. Hashimoto, M., Rao, S., Tokono, O., Yamamoto, K. I., Takata, M. and Takeda, S. et al. (2003) DNA-PK: the major target for wortmannin-mediated radiosensitization by the inhibition of DSB repair via NHEJ pathway. J Radiat Res. 44: 151-159.
23. Lim, J. W., Kim, H. and Kim, K. H. (2002) Expression of Ku70 and Ku80 mediated by NF-κB and cyclooxygenase-2 is related to proliferation of human gastric cancer cells. J Biol Chem. 277: 46093-46100.
24. Dey, A., Wong, E. T., Cheok, C. F., Tergaonkar, V. and Lane, D. P. (2008) R-roscovitine simultaneously targets both the p53 and NF-κB pathways and causes potentiation of apoptosis: implications in cancer therapy. Cell Death Differ. 15: 263-273.
25. Lu, X. H., Ellington, J., Curtin, N. L, Lunec, J. and Newell, D. R. (2001) The impact of p53 status on cellular sensitivity to antifolate drugs. Clin Cancer Res. 7: 2114-2123.